SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 143 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,404 | -44.7% | 32,350 | +19.8% | 0.00% | – |
| Q2 2023 | $35,100 | -41.7% | 27,000 | -21.1% | 0.00% | – |
| Q1 2023 | $60,192 | -29.2% | 34,200 | +26.3% | 0.00% | – |
| Q4 2022 | $85,034 | -35.6% | 27,081 | +0.3% | 0.00% | – |
| Q3 2022 | $132,000 | -98.3% | 27,000 | -96.2% | 0.00% | -100.0% |
| Q2 2015 | $7,944,000 | -29.3% | 716,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $11,232,000 | +3.1% | 716,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $10,895,000 | +31.2% | 716,300 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $8,302,000 | -43.1% | 769,800 | -19.4% | 0.00% | -33.3% |
| Q2 2014 | $14,589,000 | -26.4% | 955,400 | -12.8% | 0.01% | -33.3% |
| Q1 2014 | $19,817,000 | – | 1,096,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |